MedPath

Clinical Outcomes of Autologous Bone Marrow Aspirate Concentrate Injections for Musculoskeletal Conditions

Withdrawn
Conditions
Osteoarthritis
Sprains Strain
Tendinopathy
Musculoskeletal Pain
Interventions
Procedure: Bone Marrow Aspirate Concentrate Injection
Registration Number
NCT02981394
Lead Sponsor
Rush University Medical Center
Brief Summary

The use of Bone Marrow Autologous Collection (BMAC) in musculoskeletal conditions including osteoarthritis and tendon injuries has been growing. Outcome evidence continues to be sparse. The purpose of this study is collect a longitudinal case series of patient reported outcomes following BMAC injections for musculoskeletal conditions including osteoarthritis, tendinopathy and injuries to ligaments, tendons and muscles.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Musculoskeletal Condition that is able to undergo an injection
  • Patient requests the procedure and enrolls with agreement to pay for the procedure
Exclusion Criteria
  • Active Cancer
  • Allergies to local anesthesia

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
BMAC GroupBone Marrow Aspirate Concentrate InjectionIntervention Group
Primary Outcome Measures
NameTimeMethod
WOMAC Score5 years

Pain and Function Score

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Midwest Orthopeadics at Rush

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath